Literature DB >> 12845914

First drug-eluting coronary stent approved.

Cheryl A Thompson.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12845914     DOI： 10.1093/ajhp/60.12.1210

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

Review 1.  Rapamycin passes the torch: a new generation of mTOR inhibitors.

Authors:  Don Benjamin; Marco Colombi; Christoph Moroni; Michael N Hall
Journal:  Nat Rev Drug Discov       Date:  2011-10-31       Impact factor: 84.694

2.  Mammalian target of rapamycin (mTOR) induces proliferation and de-differentiation responses to three coordinate pathophysiologic stimuli (mechanical strain, hypoxia, and extracellular matrix remodeling) in rat bladder smooth muscle.

Authors:  Karen J Aitken; Cornelia Tolg; Trupti Panchal; Bruno Leslie; Jeffery Yu; Mohamed Elkelini; Nesrin Sabha; Derrick J Tse; Armando J Lorenzo; Magdy Hassouna; Darius J Bägli
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 3.  Synthesis and biological evaluation of rapamycin-derived, next generation small molecules.

Authors:  Shiva Krishna Reddy Guduru; Prabhat Arya
Journal:  Medchemcomm       Date:  2017-11-22       Impact factor: 3.597
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.